Interestingly, none of the mice injected with CONTROL ESCs developed teratomas up to 35 days post-inoculation, whereas mice injected with OE GRG5 ESCs developed several tumors with widespread distribution (Supplementary Fig. S3f). Here, TLE5 is linked to teratoma.